2016
DOI: 10.1111/ajt.13752
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Preemptive Fibrinogen Concentrate on Transfusion Requirements in Liver Transplantation: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
37
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 59 publications
(38 citation statements)
references
References 19 publications
1
37
0
Order By: Relevance
“…Previous studies have suggested prophylactic fibrinogen transfusion to prevent PPH, while others denied its benefit [5]. However, according to our experience, the first hour following severe PPH (golden hour) seems to be the best timing for fibrinogen concentrate infusion to reduce the blood loss, transfusion requirements and surgical hemostasis.…”
mentioning
confidence: 81%
“…Previous studies have suggested prophylactic fibrinogen transfusion to prevent PPH, while others denied its benefit [5]. However, according to our experience, the first hour following severe PPH (golden hour) seems to be the best timing for fibrinogen concentrate infusion to reduce the blood loss, transfusion requirements and surgical hemostasis.…”
mentioning
confidence: 81%
“…Implementation of FIBTEM-guided fibrinogen substitution in bleeding management algorithms during liver transplantation significantly reduced transfusion requirements for red blood cells, plasma, and platelets [31,92,97,101,[114][115][116][117][118]. In contrast, preemptive administration of fibrinogen concentrate did not influence transfusion requirements in an RCT in liver transplantation [119].…”
Section: Vol 72 No 4 August 2019mentioning
confidence: 99%
“…Notably, no additional benefit was observed in terms of RBC requirements with FIBTEM MCF values above 10 mm, which was the cut‐off beyond which fibrinogen administration may be futile and, indeed, exposes the patient to the potential undesirable effects of this drug. In the light of our previous results (the pre‐emptive administration of fibrinogen did not influence transfusion requirements ), and bearing in mind that LT is a dynamic procedure, administration of fibrinogen to maintain FIBTEM MCF above 8 mm, in case of if the patient is bleeding or it is expected to bleed, would be a more suitable approach for reducing transfusion requirement than prophylactic administration of fibrinogen.…”
Section: Discussionmentioning
confidence: 61%
“…In our previous study , we found that the administration of 3·54 g of fibrinogen (95% CI 2·95‐4·14) produced a mean increase in plasma fibrinogen of 0·32 g/l (95% CI 0·13–0·51) and a mean increase in FIBTEM A10 of 3·77 mm. These values contrast with the studies of Solomon and colleagues in patients with extracorporeal circulation, which showed higher increases in both parameters .…”
Section: Discussionmentioning
confidence: 87%